Literature DB >> 24813919

Impact of chemotherapy delay on short- and long-term survival in younger and older AML patients: a Danish population-based cohort study.

L S G Ostgard1, J M Nørgaard2, H Sengeløv3, M S Holm2, M K Jensen4, M Kallenbach5, C W Marcher6, O J Nielsen3, M Nørgaard7.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24813919     DOI： 10.1038/leu.2014.157

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  13 in total

1.  Epidemiology. When an entire country is a cohort.

Authors:  L Frank
Journal:  Science       Date:  2000-03-31       Impact factor: 47.728

Review 2.  Time-dependent covariates in the Cox proportional-hazards regression model.

Authors:  L D Fisher; D Y Lin
Journal:  Annu Rev Public Health       Date:  1999       Impact factor: 21.981

3.  Dose-response and trend analysis in epidemiology: alternatives to categorical analysis.

Authors:  S Greenland
Journal:  Epidemiology       Date:  1995-07       Impact factor: 4.822

4.  Older patients with acute myeloid leukemia benefit from intensive chemotherapy: an update from the Swedish Acute Leukemia Registry.

Authors:  Gunnar Juliusson
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2011-05-04

Review 5.  Therapeutic advances in acute myeloid leukemia.

Authors:  Alan Burnett; Meir Wetzler; Bob Löwenberg
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

6.  Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study.

Authors:  L S G Østgård; J M Nørgaard; H Sengeløv; M Severinsen; L S Friis; C W Marcher; I H Dufva; M Nørgaard
Journal:  Leukemia       Date:  2014-08-05       Impact factor: 11.528

7.  Acute myeloid leukaemia in Western Australia 1991-2005: a retrospective population-based study of 898 patients regarding epidemiology, cytogenetics, treatment and outcome.

Authors:  S A Gangatharan; C S Grove; S P'ng; J O'Reilly; D Joske; M F Leahy; T Threlfall; M P Wright
Journal:  Intern Med J       Date:  2013-08       Impact factor: 2.048

Review 8.  Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

Authors:  Hartmut Döhner; Elihu H Estey; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Alan K Burnett; Hervé Dombret; Pierre Fenaux; David Grimwade; Richard A Larson; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel A Sanz; Jorge Sierra; Martin S Tallman; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

9.  Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia.

Authors:  Sarah Bertoli; Emilie Bérard; Françoise Huguet; Anne Huynh; Suzanne Tavitian; François Vergez; Sophie Dobbelstein; Nicole Dastugue; Véronique Mansat-De Mas; Eric Delabesse; Eliane Duchayne; Cécile Demur; Audrey Sarry; Valérie Lauwers-Cances; Guy Laurent; Michel Attal; Christian Récher
Journal:  Blood       Date:  2013-01-30       Impact factor: 22.113

10.  Data quality in the Danish National Acute Leukemia Registry: a hematological data resource.

Authors:  Lene Sofie Granfeldt Ostgård; Jan Maxwell Nørgaard; Marianne Tang Severinsen; Henrik Sengeløv; Lone Friis; Morten Krogh Jensen; Ove Juul Nielsen; Mette Nørgaard
Journal:  Clin Epidemiol       Date:  2013-09-02       Impact factor: 4.790
View more
  6 in total

1.  Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012.

Authors:  A G Dinmohamed; O Visser; Y van Norden; N M A Blijlevens; J J Cornelissen; G A Huls; P C Huijgens; P Sonneveld; A A van de Loosdrecht; G J Ossenkoppele; B Löwenberg; M Jongen-Lavrencic
Journal:  Leukemia       Date:  2015-07-17       Impact factor: 11.528

2.  Analysis of Clinical Profile and Outcome of Tuberculosis in Patients with Acute Leukemia.

Authors:  Arihant Jain; Gaurav Prakash; Charanpreet Singh; Deepesh Lad; Alka Khadwal; Vikas Suri; Pankaj Malhotra; Savita Kumari; Neelam Varma; Subhash Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2017-09-12       Impact factor: 0.900

3.  Real-world challenges in the management of acute myeloid leukemia: a single-center experience from North India.

Authors:  Priyanka Chauhan; Anshul Gupta; M Gopinathan; Akanksha Garg; Smriti Khanna; Ruchi Gupta; Khaliqur Rahman; Dinesh Chandra; Manish Kumar Singh; Soniya Nityanand
Journal:  Ann Hematol       Date:  2022-03-24       Impact factor: 3.673

4.  Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications.

Authors:  Lisa Pleyer; Sonja Burgstaller; Reinhard Stauder; Michael Girschikofsky; Heinz Sill; Konstantin Schlick; Josef Thaler; Britta Halter; Sigrid Machherndl-Spandl; Armin Zebisch; Angelika Pichler; Michael Pfeilstöcker; Eva-Maria Autzinger; Alois Lang; Klaus Geissler; Daniela Voskova; Dietmar Geissler; Wolfgang R Sperr; Sabine Hojas; Inga M Rogulj; Johannes Andel; Richard Greil
Journal:  J Hematol Oncol       Date:  2016-04-16       Impact factor: 17.388

Review 5.  The Danish National Acute Leukemia Registry.

Authors:  Lene Sofie Granfeldt Østgård; Jan Maxwell Nørgaard; Klas Kræsten Raaschou-Jensen; Robert Schou Pedersen; Dorthe Rønnov-Jessen; Per Troellund Pedersen; Inge Høgh Dufva; Claus Werenberg Marcher; Ove Juul Nielsen; Marianne Tang Severinsen; Lone Smidstrup Friis
Journal:  Clin Epidemiol       Date:  2016-10-25       Impact factor: 4.790

6.  Impact of Chemotherapy Delay on Overall Survival for AML with IDH1/2 Mutations: A Study in Adult Chinese Patients.

Authors:  Jing-Han Wang; Qi Guo; Zhi-Xin Ma; Qiu-Ling Ma; Meng-Xia Yu; Xiu-Feng Yin; Sha-Sha Lu; Hong-Qiong Xie; Yue-Hong Jiang; Dan Shen; Li-Ya Ma; Hui Shi; Wen-Juan Yu; Ye-Jiang Lou; Ying Li; Min Yang; Gai-Xiang Xu; Li-Ping Mao; Jian-Hu Li; Huan-Ping Wang; Dong-Mei Wang; Ju-Ying Wei; Hong-Yan Tong; Jian Huang; Jie Jin
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.752
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.